In neoplastic conditions such as brain tumors, however, TF expression and activity can be dysregulated by various genetic and epigenetic changes including point mutations, translations, amplifications, deletions, or even extend to mutations in non-coding DNA that can affect DNA binding activity. Here, TF is linked to brain neoplasm.